Total Payments
$39,446
2024 Payments
$16,875
Companies
42
Transactions
560
Medicare Patients
2,340
Medicare Billing
$534,672
Payment Breakdown by Category
Food & Beverage$16,328 (41.4%)
Other$11,067 (28.1%)
Consulting$6,360 (16.1%)
Travel$5,680 (14.4%)
Education$11.49 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,328 | 526 | 41.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,067 | 11 | 28.1% |
| Consulting Fee | $6,360 | 3 | 16.1% |
| Travel and Lodging | $5,680 | 19 | 14.4% |
| Education | $11.49 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $16,610 | 150 | $0 (2024) |
| LivaNova USA, Inc. | $10,168 | 40 | $0 (2024) |
| NEUROPACE, INC. | $2,577 | 16 | $0 (2023) |
| Medtronic USA, Inc. | $1,335 | 9 | $0 (2019) |
| SK Life Science, Inc. | $984.61 | 35 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $982.74 | 48 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $908.20 | 39 | $0 (2022) |
| ABBVIE INC. | $558.92 | 37 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $462.00 | 25 | $0 (2024) |
| Neurelis, Inc. | $453.10 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16,875 | 128 | UCB, Inc. ($14,162) |
| 2023 | $3,899 | 93 | LivaNova USA, Inc. ($1,255) |
| 2022 | $4,147 | 75 | LivaNova USA, Inc. ($2,131) |
| 2021 | $2,609 | 50 | LivaNova USA, Inc. ($1,611) |
| 2020 | $2,612 | 39 | LivaNova USA, Inc. ($1,873) |
| 2019 | $3,893 | 96 | Medtronic USA, Inc. ($1,335) |
| 2018 | $4,773 | 59 | NEUROPACE, INC. ($1,895) |
| 2017 | $637.44 | 20 | Supernus Pharmaceuticals, Inc. ($234.33) |
All Payment Transactions
560 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Neurology | ||||||
| 12/08/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $140.79 | General |
| Category: Neurology | ||||||
| 12/06/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $98.25 | General |
| 12/06/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $96.73 | General |
| 12/04/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: EPILEPSY | ||||||
| 12/03/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $11.63 | General |
| 11/19/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: Neurology | ||||||
| 11/18/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $61.68 | General |
| Category: Neurology | ||||||
| 11/13/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: Neurology | ||||||
| 11/08/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $18.53 | General |
| 11/06/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: Neurology | ||||||
| 10/31/2024 | UCB, Inc. | Fintepla (Drug) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 10/29/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: Neurology | ||||||
| 10/24/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $79.70 | General |
| Category: Central Nervous System | ||||||
| 10/23/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: Neurology | ||||||
| 10/22/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Neurology | ||||||
| 10/18/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $19.84 | General |
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Neurology | ||||||
| 10/05/2024 | UCB, Inc. | Fintepla (Drug) | Travel and Lodging | In-kind items and services | $303.97 | General |
| Category: Neurology | ||||||
| 10/05/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: Neurology | ||||||
| 10/05/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Neurology | ||||||
| 10/05/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Neurology | ||||||
| 10/04/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $138.00 | General |
| Category: Neurology | ||||||
| 09/23/2024 | LivaNova USA, Inc. | VNS Therapy (Device) | Travel and Lodging | Cash or cash equivalent | $212.41 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 648 | 1,087 | $449,041 | $140,362 |
| 2022 | 10 | 528 | 906 | $362,408 | $126,681 |
| 2021 | 12 | 589 | 998 | $421,692 | $155,232 |
| 2020 | 13 | 575 | 896 | $330,793 | $112,397 |
Total Patients
2,340
Total Services
3,887
Medicare Billing
$534,672
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 138 | 353 | $200,984 | $63,452 | 31.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 258 | 433 | $168,221 | $53,145 | 31.6% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 60 | 61 | $22,338 | $7,035 | 31.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $13,860 | $4,127 | 29.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 54 | $10,206 | $3,776 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 37 | $10,684 | $3,104 | 29.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 16 | 16 | $7,203 | $2,265 | 31.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 26 | 26 | $3,993 | $1,276 | 32.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 17 | 17 | $2,627 | $835.71 | 31.8% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 21 | 29 | $2,604 | $799.94 | 30.7% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2023 | 22 | 36 | $6,322 | $546.65 | 8.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 233 | 398 | $147,260 | $57,514 | 39.1% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 116 | 295 | $159,964 | $52,054 | 32.5% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 36 | 37 | $12,904 | $4,241 | 32.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $11,088 | $3,758 | 33.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 38 | $9,833 | $3,318 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 22 | $6,050 | $1,992 | 32.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 32 | 32 | $4,680 | $1,334 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 18 | $3,384 | $1,278 | 37.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 14 | 14 | $2,061 | $723.58 | 35.1% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2022 | 17 | 31 | $5,185 | $468.47 | 9.0% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 154 | 329 | $178,400 | $61,513 | 34.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 212 | 399 | $147,894 | $59,880 | 40.5% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2021 | 27 | 27 | $31,331 | $12,090 | 38.6% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 58 | 59 | $20,576 | $7,200 | 35.0% |
About Dr. Mohankumar Kurukumbi, M.D
Dr. Mohankumar Kurukumbi, M.D is a Neurology healthcare provider based in Alexandria, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2008. The National Provider Identifier (NPI) number assigned to this provider is 1871752279.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohankumar Kurukumbi, M.D has received a total of $39,446 in payments from pharmaceutical and medical device companies, with $16,875 received in 2024. These payments were reported across 560 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($16,328).
As a Medicare-enrolled provider, Kurukumbi has provided services to 2,340 Medicare beneficiaries, totaling 3,887 services with total Medicare billing of $534,672. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Clinical Neurophysiology, Neurology
- Location Alexandria, VA
- Active Since 06/02/2008
- Last Updated 01/13/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1871752279
Products in Payments
- Fintepla (Drug) $9,528
- VNS Therapy (Device) $5,120
- Briviact (Drug) $3,587
- Nayzilam (Drug) $2,612
- RNS System (Device) $2,268
- VNS Therapy SenTiva Model 1000 Generator (Device) $2,131
- VNS - Sentiva (Device) $1,611
- ACTIVA (Device) $1,335
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $1,305
- APTIOM (Drug) $1,295
- TROKENDI XR (Drug) $886.50
- BOTOX (Biological) $517.20
- VALTOCO (Drug) $453.10
- PERCEPT PC BRAINSENSE (Device) $406.89
- RNS Neurostimulator Kit (Device) $308.64
- NUEDEXTA (Drug) $262.55
- AUBAGIO (Drug) $246.28
- FYCOMPA (Drug) $202.58
- SOLIRIS (Drug) $195.14
- EPIDIOLEX (Drug) $184.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Alexandria
Ramsey Falconer, M.d, M.D
Neurology — Payments: $1.8M
Neurology $1.8M
Dr. John Cochran, M.d, M.D
Neurology — Payments: $219,097
Neurology $219,097
Richard Ospina, M.d, M.D
Neurology — Payments: $48,298
Neurology $48,298
Dr. Eric Sklar, M.d, M.D
Neurology — Payments: $45,118
Neurology $45,118
Dr. Sean Rogers, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $33,366
Neurology $33,366
Dr. Peter Bernad, M.d., M.p.h., Facp, M.D., M.P.H., FACP
Neurology — Payments: $18,248
Neurology $18,248